Activation of lymphocytes in mammals is often quantified by measuring the amount of proliferation during the expansion phase of an immune response. Bromodeoxyuridine (BrdU) incorporation and carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution assays are some of the techniques widely used in mammalian studies of pathogeninduced proliferation and provide a convenient way of quantifying the cellular response. We have extended the use of these proliferation assays to the amphibian Xenopus laevis. We have developed this species as a valuable comparative model to study immunity against a wellknown amphibian pathogen, Frog Virus 3 (FV3). Fluorescence activated cell sorting was used to assess the level of BrdU incorporation of lymphocytes in vivo and CFSE dilution in an in vitro activation assay. Both techniques have shown that splenic lymphocytes proliferate specifically upon FV3 challenge. This indicates that common methods for detection of proliferation upon immunologic challenge are easily applied to other vertebrate species, as it highlights the evolutionary conservation of the proliferative nature of immune responses throughout vertebrate phyla.
INTRODUCTION
At the start of an immune response in lymphoid organs, naive T lymphocytes are activated and proliferate in response to antigens (Ags) presented in the context of the major histocompatibility complex (MHC) receptors by professional antigen presenting cells (APCs). Effective pathogen clearance depends on the clonal expansion and maturation of T lymphocytes into T cell effectors that can recognize and act against specific Ags (1) . Therefore, the measure and quantification of the level of proliferation in vivo in lymphoid organs as well as in vitro in cell cultures has become a staple of immune response assessment. The thymidine incorporation assay is a very common technique that measures lymphocyte responses by determining the amount of radioactive nucleotide incorporated into the DNA of proliferating cells in an in vitro culture after exposure to activating stimuli (2, 3) . A higher cell number due to proliferating cells results in a higher radioactive signal. Methods that use fluorescence activated cell sorting (FACS) to identify populations of proliferating cells have proven convenient and safe since they require no radioactivity and are more informative since they allow monitoring proliferation of distinctive cell populations identified by specific markers on their cell surface (4, 5) . Proliferation assays using multiparametric FACS have allowed the identification of differentially expanding T cells both in vivo (6) and in vitro (7) and have revealed the kinetics of T cell activation upon antigenic challenge over time. The two main methods widely used in mammals are bromdeoxyuridine (BrdU) incorporation and carboxyfluorescein diacetate succinimidyl ester (CFSE) staining.
BrdU is a thymidine analogue that incorporates into newly synthesized DNA of cells at the S phase of the cell cycle (8) . Antibodies specific to BrdU are used to determine the presence 2 of the molecule in the genomic DNA and the number of cells that have incorporated it. Because BrdU is intracellular, antibodies specific to surface molecules can also be used to identify the cell types incorporating BrdU in a given population. The use of a specific antibody to nascent DNA makes it a useful technique for immunohistochemical, cytometric and microscopic analyses (9) .
An alternative to BrdU incorporation assays, and not based on DNA synthesis, is the use of CFSE, a membrane permeable nontoxic fluorescent dye also widely used for the detection of immune cell proliferation in vitro (10) . CFSE incorporates at similar levels into all cells but dilutes two fold at each cell division. This permits the detection of up to 10 cellular divisions and therefore provides a more robust quantification of the proliferation by a cell population than BrdU incorporation (5).
Whereas activation and expansion of T cells during antiviral responses are well characterized in mammals (1114) very little is known about the proliferative capacity of activated T lymphocytes against viral pathogens in coldblooded vertebrates. In one account, cells isolated from trout kidneys were shown to proliferate in response to adherent cells that had been stimulated previously with a recombinant viral protein that act as antigen presenting cells (15) . However, due to the lack of antibodies that recognize specific surface markers in this species, a more detailed analysis of the nature of proliferating cells is missing. We have established Xenopus as an important model with which to study immunity against ranaviruses (Iridoviridae) in amphibians (16) and showed evidence of the critical role of splenic lymphocytes, in particular CD8 T cells, in host resistance to Frog Virus 3 (FV3) infection (17) . Proliferation of splenic CD8 T cells upon FV3 infection has been recently characterized in vivo using a BrdU incorporation method and fluorescence activated cell sorting (FACS) (18) . In this review, we describe in detail these methods, adapted for Xenopus, to monitor the proliferating responses to virus of splenocytes, including total T cells, CD8 T cells and IgM+ B cells.
MATERIALS AND METHODS

Animals, reagents and FV3 stocks
Twoyear old (about 3 in. long) outbred Xenopus adults, and monoclonal antibodies (mAbs) specific to Xenopus CD8 (AM22; 19), Class II (AM20, 19) and IgM (10A9; 20) were obtained from the X. laevis Research Resource for Immunobiology at the University of Rochester Medical Center (http://www.urmc.rochester.edu/smd/mbi/xenopus). Frog Virus 3 (FV3, Iridoviridae) was grown in and purified from A6 Xenopus kidney cell line as previously described (16) . Viral titers were determined using A6 cells by the 50% endpoint dilution method. Randomized groups of frogs were inoculated by intraperitoneal injection of 5 x 10 6 pfu of FV3 in 300 l of μ PBS modified to amphibian osmolarity (APBS). All animals were handled under strict laboratory and UCAR regulations (Approval number 2004199), minimizing discomfort at all times.
In vivo BrdU incorporation assay
Outbred adult frogs were injected once with 3x10 6 pfus FV3 and incubated for 3, 6, 9 and 14 days. Frogs were then incubated in 100ml of water containing 1mg/ml bromodeoxyuridine (BrdU, Sigma St. Louis, MO; Catalog #B50021G) 2 days before sacrifice. Splenocytes were washed 2x in APBS, counted and stained for surface markers CD8 (AM22, IgM isotype), Class II (AM20; IgG1 isotype) and IgM (10A9; IgG1 isotype) followed by APC conjugated Goat anti Mouse mAb (Accurate JGM136146). Cells were washed in APBS/0.05% Tween to permeabilize and treated with DNase (Sigma DN251G) followed by incubation with FITC conjugated anti BrdU mAb (Roche 1202693). Cells were then washed and analyzed by flow cytometry using a FACS Calibur (BD Biosciences). 20,000 events were collected and the lymphocyte population was gated based on their forward and side scatter profiles.
In vitro CFSE proliferation assay
Peritoneal leukocytes (PLs) from outbred frogs infected once for 3weeks with 3x10 6 pfu FV3 (primed) or uninfected (unprimed) were isolated by peritoneal lavage (2), washed with APBS and infected with FV3 at 1 multiplicity of infection (MOI) for 24 hours in 1ml amphibian grade culture medium (ASFA6) in 24 well plates. Twentyfour hours later, spleens harvested from the same outbred frogs were scraped using a nylon mesh and washed two times with APBS. Cells were labeled with 5 M μ CFSE (Sigma 21880) for 20 min. at 27°C in the dark and washed 3 times with APBS. Splenocytes were added to infected PLs at a 1:1 ratio for 24, 48 and 72 hours. For FACS analysis, total co culture cells were washed twice in APBS and stained using Xenopus specific mAbs, as mentioned above.
RESULTS AND DISCUSSION
Antiviral lymphocyte proliferative responses monitored in vivo by BrdU incorporation in Xenopus
To assess the in vivo proliferative response of Xenopus splenocytes during viral infection, we adapted the BrdU incorporation assay used in the mouse model (5) . Adult frogs were injected intraperitoneally with the iridovirus FV3 and treated with 1mg/ml of BrdU directly added in the water 2 days before sacrifice. A representative experiment is depicted in Fig.  1A . Forward scatter and side scatter profiles of Xenopus splenocytes are comparable to that of mammals, indicative of small cells with little to no granularity. The slight increase in the size of the lymphocytes (indicated by an arrow in Fig. 1 forward scatter and side scatter plots) in infected frogs compared to the uninfected controls suggests activation and consequent blasting of lymphocytes in the spleen as observed in mammals and ectothermic vertebrates (21) . Similarly, the total number of splenocytes, as well as BrdU+ cells, obtained from infected frogs was substantially higher than uninfected frogs, indicating an expansion of cells due to immune activation (Fig. 1) .
Gating was done on cells with size characteristics of lymphocytes (also the most prominent population in the spleen) in both infected and uninfected samples for analysis of surface markers and BrdU ( Figs. 1 and 2 ). Although some BrdU incorporation was detected in lymphocytes from uninfected animals, a significantly higher fraction of lymphocytes in the infected frog had incorporated BrdU (Fig. 1 histograms) . About 7% of total splenocytes in the infected frog incorporate BrdU versus 3% in the uninfected control. The low level of proliferation detected in uninfected animals is possibly due to the basal homeostatic proliferation of various lymphocyte subsets or an unidentified immune response in that animal, given that animals in our facilities are not germ free. To determine the cell types involved in the proliferative response upon FV3 infection, we took advantage of Xenopus specific mAbs recognizing cell surface markers such as CD8 for T cells, MHC class II for all lymphocytes and IgM for B cells. As previously described in detail (18), CD8 T cells constitute the main lymphocyte effectors proliferating in response to FV3 infection. We recently found that IgM+ B cells also undergo a marked proliferative response against FV3, albeit lower than CD8+ lymphocytes (Fig. 2, far right panels) . In addition, surface IgM expression in BrdU negative cells of the infected sample was increased from 2% to 11%, (Fig 2) . This result further substantiates earlier observations of B cell activation during a primary FV3 response, which is necessary for the establishment of memory B cell responses observed during a secondary response (22) . Furthermore, proliferation in the spleen is due entirely to immune cells since no MHC class II negative cells proliferate (e.g., incorporate BrdU) upon FV3 challenge during the times tested (Fig. 2 , lower right quadrants of MHCII dot plots).
These results show that proliferation of immune cells in the spleen of an ectothermic vertebrate upon pathogenic challenge can be monitored in vivo by a BrdU incorporation assay as it is done in mammals, and further highlights the improvement of immunologic techniques in X. laevis.
Antiviral lymphocyte proliferative responses monitored in vitro by CFSE dilution assay in Xenopus
Our previous study has provided in vivo evidence of an accelerated CD8 T cell response during secondary viral challenge (18) . These results suggest that CD8 T cells were efficiently primed during the primary antiviral response and that memory T cells were generated. To further characterize the proliferative response of primed T cells, we have developed an in vitro proliferation method using CFSE, which is a fluorescent dye that incorporates into all viable cells. Upon cell division, CFSE is equally distributed in each daughter cell, making it possible to measure each dividing cell from the parent cell as diluted CFSE in a population.
We have characterized peritoneal leukocytes (PLs) likely to be antigenpresenting cells in Xenopus laevis (Morales and Robert unpublished results). During FV3 infection, in vivo, cells in the peritoneum increase in number and size, and macrophagelike cells constitute roughly 3050% of total peritoneal leukocytes. To test whether macrophagelike cells in the peritoneum act as antigen presenting cells, PLs were isolated from 3 week primed animals and infected in vitro with 1MOI FV3 for 24hours, then cocultured with CFSEstained splenocytes from the same animal for 72 hours. Unprimed CFSE stained splenocytes co cultured with infected PLs from the same animal were used as a negative control. The profiles of both in vitro cocultures at time 0 shows an expected high CFSE content in splenocytes, which have not yet begun to proliferate (representative show in Fig. 3 top panel) . Given the low number of PL's in the culture, no CFSE negative population is visible. The dot plots in combination with multiple conditions to test antigen presentation and pathogen specificity of which little is known in ectothermic vertebrates.
To our knowledge, this is the first account of a measurable proliferative response of lymphocytes against a viral pathogen in an ectothermic vertebrate. We have shown that commonly used techniques to determine lymphocyte proliferation in mammals can also be applied to assess cellular immune responses in amphibians. We have previously shown that CD8 T cells involved in antiranaviral response in Xenopus proliferate (e.g., incorporate BrdU) at detectable levels in the spleen, in both primary and secondary infections. Furthermore, T cell priming resulting from FV3 infection can be determined in vitro by co culture of primed splenocytes with antigen presenting cells infected with FV3. The use of CFSE in this instance allows a rigorous analysis of the level of proliferation of various Xenopus lymphocyte populations. It is noteworthy that in both BrdU and CFSE based assays, proliferation of activated lymphocytes was minimal compared to that observed in mammals (4, 7) . We have suggested that the relatively small response of Xenopus lymphocytes may be due to the lack of secondary lymphoid organs such as the lymph nodes, which facilitate intimate contact with the antigen presenting cells (22, 23) . However, since we also observe this effect in vitro, it may be due to intrinsic characteristics of the cellular potential in this ectothermic vertebrate. We speculate, for example, that the effect of cytokine secretion in Xenopus may be limited by either a relatively lower amount of secreted cytokine, diminished receptor expression in the cell surface or a lack of those cytokines specifically involved in boosting T cell proliferation in mammals (i.e. IL2, IL17 and IL15).
Some technical issues concerning the use of BrdU and CFSE in Xenopus splenocytes are discussed below. The DNAse treatment in the BrdU incorporation assay, which opens the genomic DNA and allows the antibody access to the BrdU epitope, is damaging and results in loss of cells; about 100,000 to 500,000 (or 2050% of starting cell numbers) cells can be lost in a single DNase treatment. While a lower DNase concentration diminishes cell loss, it also decreases the intensity of the specific signal, and ultimately, the number of positive cells. Optimal results were obtained when the initial total number of cells per sample was increased (about 1x10 6 cells/sample), a feasible approach since about 1020 million total cells can be isolated from a single Xenopus adult spleen. Another problem inherent to the laborious nature of the BrdU assay are the multiple washing steps necessary for the elimination of crossreactive binding, and that can also contribute to a considerable loss of cells. We found that suction of the washing and staining buffers with a Pasteur pipette connected to a vacuum pump rather than decanting after centrifuging minimized cell loss.
CFSE staining of Xenopus splenocytes has been successfully used before in adoptive cell transfer experiments (23), but multiple concentrations of CFSE were tested to obtain optimal staining of splenocytes. Cytotoxicity caused by CFSE is observed at levels over 50 mM for approximately 20x10 6 total cells, but a 5 M μ CFSE concentration was optimal and no cytotoxicity was observed (see T 0 on Fig. 3) . In contrast to thymidine incorporation assays, the CFSE proliferation assay is more informative since, with the use of flow cytometry it allows the identification of proliferating cells by specific surface markers. Furthermore, while CFSE can identify the effector cell population the serial dilutions observed in a dot plot can indicate the intensity of the effector response. In contrast, effector cell proliferation in thymidine incorporation assays may be masked by spontaneous proliferation of stimulator cells or by cell death, resulting in high background and an underestimation of the effector response. Repeated experiments have yielded consistent results and have rendered the CFSE proliferation assay as a valuable and reliable tool in our studies.
One common caveat for the use of green fluorochrome dyes in amphibian cells is autofluorescence and, given the emission spectrum of diluted CFSE, distinguishing true proliferation from autologous fluorescence using FACS can be challenging. However, this is easily circumvented by the use of an unlabeled control to determine basal level autofluorescence. Fortunately, the color intensity of the initial CFSE staining is significantly higher than autofluorescent Xenopus cells and diluting CFSE cell populations can be easily distinguished in a flow cytometry dot plot (see bottom panels in Fig. 3) . Furthermore, given that autofluorescence does not vary significantly from individual to individual, comparisons between treated and untreated samples can provide a standard of autofluorescence usable in all experiments.
Overall, our studies show that both BrdU and CFSE are reliable cell labeling techniques for identifying and measuring the amount of proliferating cells in Xenopus spleen and splenocyte cultures, respectively. Both are relatively simple to perform and have the advantage of measuring cell type specific activation. It is safe to say that many methods used in mammals to assess immune cell function are easily transferable to other vertebrate models, further bridging the gap to a complete understanding of cellular immune responses throughout vertebrate phyla.
